Bronchiolitis obliterans organizing pneumonia as the pulmonary manifestation of lupus: A review of three cases

Lupus ◽  
2020 ◽  
pp. 096120332096743
Author(s):  
Ritasman Baisya ◽  
Phani Kumar Devarasetti ◽  
Shantveer G Uppin ◽  
Ramakrishna Narayanan ◽  
Liza Rajasekhar ◽  
...  

Objective Bronchiolitis obliterans organizing pneumonia (BOOP) is a clinico-patho-radiological diagnosis which rarely presents as a pulmonary manifestation of lupus. In this concise report, organizing pneumonia was found as the sole pulmonary manifestation of SLE in different age groups. Method All three patients diagnosed with SLE according to SLICC 2012 classification criteria, were admitted in rheumatology ward of NIMS hospital, Hyderabad, India from May to November, 2018. Their diagnosis of BOOP was either biopsy proven or imaging guided. Review of literature was done with MeSH terms (SLE, BOOP) in PubMed and approximately 10 articles were reviewed including latest of 2019 published in Scientific Reports. Result There were three patients – one juvenile lupus and two adults. Two patients were male and one female. All three patients had SLE with high disease activity. They all had organising pneumonia as pulmonary manifestation with other organ involvement. Juvenile patient had a fatal outcome while the others had a good recovery with steroid and immunosuppressive. Conclusion BOOP is a rare pulmonary manifestation in lupus. It can be diagnosed early with more precision using computerised tomography of lung without waiting for biopsy report. This will result in a better prognosis by rapid initiation of corticosteroid and immunosuppressive treatment.

2005 ◽  
Vol 59 (3) ◽  
pp. 315 ◽  
Author(s):  
Jong Hoo Lee ◽  
Myung Jae Park ◽  
Yi Hyung Kim ◽  
Byung Jo Park ◽  
Won Taek Oh ◽  
...  

2004 ◽  
Vol 10 (3) ◽  
pp. 456-459 ◽  
Author(s):  
Roopa Kohli-Seth ◽  
Claude Killu ◽  
May Jennifer Amolat ◽  
John Oropello ◽  
Anthony Manasia ◽  
...  

Author(s):  
Gaurav Bhardwaj ◽  
Vikram Kumar Jain ◽  
Anubhav Sharma ◽  
Lokesh Maan

ABSTRACT Methotrexate is one of the most widely used broad-spectrum immunomodulator. It can be used as a primary option or as in combination of drugs in various immunological conditions. Generally, it is safe when use in lower dosages. However, a clinician has to be alert regarding some of its less common but toxic side-effects. Here, we discuss a rare case who developed methotrexate-induced pulmonary toxicity. How to cite this article Mishra M, Jain VK, Sharma A, Bhardwaj G, Maan L. Methotrexate-induced Pulmonary Toxicity Bronchiolitis Obliterans Organizing Pneumonia: A Rare Entity. J Mahatma Gandhi Univ Med Sci Tech 2016;1(2):64-65.


Sign in / Sign up

Export Citation Format

Share Document